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Objectives: This research investigates the instruments currently available to measure the cancer 
patient experience of health care. An investigation of the number of instruments, the domains 
covered by the instruments, and the structure and psychometric performance of instruments is 
undertaken.  
Methods: A narrative synthesis approach is used to gather evidence from multiple studies and 
explain the findings. Purposely broad search terms and strategy are used to capture studies with 
cancer patients at all stages of disease and across a range of cancer types and health care settings. 
Results: The majority of identified instruments were originally designed for the oncology field. 
Twelve of the studies developed new cancer patient measures; eight studies adapted existing or 
utilised items from existing instruments, seven studies assessed the psychometric properties of 
existing instruments or assessed validated tools under different conditions (e.g. cross cultural 
adaptation).  The number of instruments assessing cancer patient experience that have sound 
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retest reliability, construct, convergent and discriminant validity, scale variability (floor/ceiling 
effects) and interpretability: Conclusion: This review examined ten years of research on the 
development of instruments to measure the cancer patient experience of health care. It found that 
research in this area is still in early stages of development. Further inquiry based development 
and validation of cancer patient experience measures is required to support improvements in 
cancer care based on the perspective of cancer patients.  
Keywords 




Clinical oncology has taken a lead in patient centred care in an effort to better support the often 
lengthy and arduous cancer patient journey (i.e. diagnosis, treatment, care and ongoing 
management), as the care journey strongly influences cancer patients‟ psychological wellbeing 
and perceived quality of life.
1
  What is less clear is the extent to which purpose designed, 
psychometrically sound measures are available to assess the cancer journey from the patient‟s 
perspective and provide additional confidence to health services in changing cancer care 
practices based on their results. Researchers suggest that establishing a valid set of patient 




























ACCEPTED MANUSCRIPT 4 
Activity in healthcare quality assessment has grown since the 1960s with the improvement focus 
of many of the measures continuing to be defined from the perspectives of clinicians and health 
administrators.
3 
More recently, collecting and engaging with patient feedback with the aim of 
supporting care that is tailored to the requirements of patients is growing in importance. Whether 
or not these processes of measurement and reporting have caused a marked impact on health 
outcomes is not clear. Regardless, patient reported measures aimed at facilitating improvement 





The use of patient reported measures is often an attempt to identify the degree to which health 
care is „patient-centred‟, the key features of which are defined as: identifying and respecting 
patient choices; informing and involving patients; involving patients in health care processes; 
treating patients with dignity; ensuring health care processes match patient needs; access to 
relevant health information; and continuity of care.
5
 To ensure translation of these features into 
care processes, patient experience data must be sufficiently and accurately captured. Until 
recently, patient experience and other complex subjective patient reported themes were 
considered beyond the scope of accurate measurement. However a growing body of evidence has 
now shown that aspects of care from the patient‟s perspective can be measured in purpose 
designed and tested instruments, providing convenient numerical summaries of features of the 
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Assessments of patient reported healthcare measures are undertaken in various ways by 
numerous groups, at different times in a patient‟s care process via a number of methods.  The 
instruments often include measures from across various areas such as patient reported: 
preferences; experiences; outcomes; and/or satisfaction with care. Collecting and cross-
referencing information across these domains provides a rich platform on which care might be 
transformed and more information provided on what is important to patients than would 




When examining instruments that measure what matters to patients, one of the most important 
considerations is establishing the fidelity of the instrument. Numerous properties are tested to 
give confidence that instruments are measuring what they are designed to measure. These 
properties include: reliability (i.e. produces consistent results in repeated measurements of the 
same circumstance or event); validity (i.e. the measure is related to the dimension it is supposed 
to assess (i.e. face validity); whether it covers the whole dimension it is supposed to assess (i.e. 






This work is part of a larger project investigating the cancer patient experience field overall.
8
 The 
aim of this inquiry is to investigate the instruments currently available to specifically measure the 
cancer patient experience of health care. An investigation of the number of instruments, the 
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instruments is conducted.  The present work builds on a number of existing global reviews of 
instruments that measure cancer patient reported measures including patient satisfaction, 
experience and quality of life measures.
9,10  
This research specifically focuses on the body of 
advances reported in the most recent literature (>2005) on instruments designed to principally 




A narrative synthesis approach is used to gather evidence from multiple studies and explain the 
findings. This approach is most suited to diversity in evidence and allows investigators to draw a 
picture of the overall knowledge and practice of the area under investigation.
11
 For the purpose 
of this review, cancer refers broadly to all types of cancer, except paediatric cancers. The patient 
experience is defined as “the patient‟s interpretation and evaluation of everything they see, feel 
and hear while receiving care from a health facility. Patient experience impacts the whole 
patient journey, from pre-care to clinical care to follow-up care and everything that happens in 
the „gaps‟”.12 
 
Inclusion criteria for this review were primary studies targeting adult cancer patient populations (i.e. 
aged 18 years or older); published in English; were published between 2005 and April 2015; 
reported the development and/or psychometric evaluation or validation of cancer patient reported 
experience measures; or reported the validation of an existing cancer patient specific measure for 
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cancer patient population in another comparable country).  Exclusion criteria included reviews, 
editorials, commentaries and research protocol papers; papers that predominately surveyed cancer 
patients under 18 years of age; papers that used an existing tool to evaluate cancer patient 
experience/satisfaction unless they provided additional useful advice; and papers that measured 
symptom burden only.  
 
A systematic multiple method search strategy has been used in this review.
13
 Table 1 provides a 
summary of the search strategy and search terms which were purposely broad to capture studies 
with cancer patients at all stages of disease and in different settings. The Scopus, PubMed, 
Medline, Embase, CINAHL, PsycINFO and Informit databases were systematically searched. 
Reference sections of textbooks and journal articles on cancer patient reported assessments, as 
well as major applicable journals (i.e. Journal of Clinical Oncology, European Journal of 
Cancer; Cancer; BMC Cancer; Supportive Care in Cancer) were hand-searched to check for 
additional relevant publications. Expert organisations currently working in field were also 






Keyword and secondary searches yielded 54 papers in total. Two reviewers independently 
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papers that were published prior to 2005; non-English papers where translations were 
unavailable; and studies set in developing countries left a total of 35 papers for inclusion. A 
further 9 papers were excluded as not investigating patient-reported measures. The full text was 




Twenty-six peer-reviewed research papers, which met the inclusion criteria and were of 
sufficient quality, were analysed. The assessed psychometric measurement properties of the 
cancer patient experience instruments in the studies were tabled (i.e. responsiveness, internal 
consistency, content validity, criterion validity, construct validity, interpretability, reproducibility 
and floor and ceiling effects)
14
 and are available in Table 2. A summary of included studies is 
available in Table 3. An assessment of quality of academic papers was undertaken using the 
Critical Appraisal Skills Programme.
15
 The Critical Appraisal Skills Programme (CASP) grew 
out of the work of the UK Critical Appraisal Skills Project in Oxford. The programme aims to 
support the appraisal of scientific evidence. Underpinned by a number of expert developed 
assessment checklists, CASP appraises the broad issues that need to be considered systematically 
when appraising research including considering if research is unbiased, results valid and an 
assessment of the importance of the results.
16  
Two reviewers independently assessed each study 



























ACCEPTED MANUSCRIPT 9 
 
Study characteristics 
The studies included in this review were primarily multi-method observational studies. Seven 
were conducted in The Netherlands
2,17-22
, six in the United States of America
23-28
 , four in the 
United Kingdom
29-32


















Cancer patient experience was solely measured in six of the 26 studies.
17,18,29,38,26,31
 The 
remaining studies measured a combination of cancer patient experience and satisfaction except 
for one of the two Australian studies which measured needs related to the cancer patient 
experience of care.
35
 Four of the included studies recruited cancer patients from treatment or 
diagnostic centres or clinics
24,28,33,34
, two from a national insurance company database
17,18 
and 
one study recruited patients via a population based cancer registry.
23
  The remaining studies 
recruited cancer patients from hospitals (inpatient and outpatients areas) or multiple settings 
including mailed surveys post hospital discharge or clinic visit. Study objectives differed across 
the included studies, with some utilising existing instruments as a base on which to add and test 
new items. Some investigators developed short form versions of existing instruments or 
attempted to validate psychometric properties of existing instruments, while others assessed 
validated tools under different conditions (e.g. cross cultural adaptation) or developed new 
cancer patient measures (and undertook some preliminary validation). Some undertook a 
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each study ranged from 52 to 7,212. Almost 83% of the examined studies had over 100 
participants. Response rates varied from 43% to 87%. 
 
Target 
A number of studies specifically targeted single cancer types i.e. five breast cancer 
specific
17,18,19,20,34
 , two targeting head and neck cancer
21,30
, one targeting small cell lung cancer
2 
and one targeting prostate cancer
31
. Four studies included selected multiple cancer types.
23,26,28,33  
The remaining studies involved instruments measuring care experience among any adult cancer 
type. Instruments within the included studies assessed discrete medical treatments (such as 
chemotherapy) or service types (such as palliative care), while others focused on
 
more general 
aspects of cancer care. One of the included studies investigated interpersonal or communication 
aspects of care interactions with healthcare providers,
21
  others also assessed experience and 
satisfaction with technical skills or clinical management
22





Instrument development and structure 
The majority of identified instruments across the included studies were originally designed for 
the oncology field. The newly developed instruments and those adapted from existing tools 
underwent a staged process of development which commonly included the generation of 
preliminary items, often using cancer patient interviews and/or focus groups, consultation with 
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based cancer management guidelines. Pilot testing to support readability, interpretability/clarity 
and/or content validity was then frequently undertaken. Larger studies were then conducted to 
field test the final agreed item set and assess some or all of their psychometric properties. All but 
one of the instruments examined in the studies was based on a multidimensional framework with 
the number of items (i.e. patient questions) ranging from 15 to 152, within 1 to 15 different 
domains (i.e. categories).  
Psychometric performance 
The number of instruments assessing cancer patient experience that have sound psychometric 
properties across items was found to be low, a finding also reported in reviews of patient 
reported measures overall. The properties least tested were test-retest reliability, construct, 
convergent and discriminant validity, scale variability (floor/ceiling effects) and interpretability. 
The psychometric measurement properties tested in each instrument evaluated in this review can 
be found in Table 2. The European Organisation for Research and Treatment of Cancer 
(EORTC) IN-PATSAT32 survey
17
 which was designed to evaluate the cancer inpatient‟s 
perception of the quality of cancer care, and its organisation, is one of the strongest studies in 
terms of validity and reliability of a variety of items. So too is the REPERES-60
18 
survey which 
was designed to measure breast cancer patients‟ experience/ satisfaction of care. A number of the 
dimensions explored by the REPERES-60 survey are also found in the IN-PATSAT32 (exchange 
of information, information provision, interpersonal skills, availability, access, technical skills, 
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Discussion 
It is now generally recognised that there is a need for rigorous approaches to obtain patients' 
views on the care they receive. As a result, much effort has, and continues to be, committed to 
developing and evaluating survey measures that reflect healthcare experiences. Sound 
psychometric properties support an understanding of the „if‟ and „how well‟ an instrument 
measures cancer patient experience. Test-retest reliability was one property least tested in the 
studies examined. This potentially means that the measures examined may not provide similar 
results if administered at different times, even with the same cohort. The complexity of the 
cancer journey is often reflected in an unpredictable care routine, which emphasises the need for 
consistency in results of cancer patient experience measurements if improvement requirements 
are to be accurately identified and acted upon. Language and cultural issues have also been 
shown to affect test-retest reliability, making the direct implementation of instruments developed 
in other countries problematic.
29
 Construct validity, which reflects the ability of the instruments 
to measure cancer patient experience, was also inadequately tested across the studies examined 
in this review. If instruments cannot provide confidence in their ability to measure cancer patient 
experience, they are much less likely to be applied in practice. A further gap in the testing of 
instruments was the responsiveness of the instruments to change and/or how well they capture 
variances in cancer care processes. The relational aspects of the different cancer patient 
experience measures are also largely unidentified (e.g. do some measures inform, augment or 
diminish others etc.). Poorly understood from existing studies is also the extent to which the 
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The value of using reliable measures to investigate cancer patient perceptions of their care 
experiences lies in the opportunity to understand the result of clinical procedures, practices and 
environment from the cancer patients‟ perspective, and generate information that can be used to 
improve care from this perspective. The interpretability of the results in relation to the potential 
effect on cancer patients was not explained in the included studies i.e. the relationship between 
results and the impact on the quality of the cancer care experience. This may be because there is 
no current agreed detailed definition of what the cancer patient experience means and which 
elements or stages are most important; therefore operationalising and measuring it with any real 
precision is currently very difficult. An ideal healthcare measure is said to have several key 
characteristics: (i) is based on agreed definitions; (ii) is specific and sensitive; (iii) is valid and 
reliable; (iv) discriminates well; (v) relates to clearly identifiable occurrences for the user; (vi) 
permits useful comparisons; and (vii) is evidence-based.
38
 It may never be possible to establish 
the cancer patient journey that is best from the viewpoint of all patients or the true value placed 
on different aspects of cancer care by different patients at different times in the cancer journey.  
This review examined a decade‟s worth of research on the development of instruments to 
measure the cancer patient experience of health care. Overall, it found that research in this area is 
still in the early stages of development and the extent to which the application of existing patient 
experience measures has led to improvements in patient centred care is unclear from existing 
literature on the topic. Moreover, when this area is compared to other complex healthcare 
measures, stark differences in progress are highlighted. For example, compared to patient 
experience measures, a much larger body of research has long been devoted to the development 
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of research publications, HRQOL studies surpass all other topics, for example, in the two years 
between 1988 and 1990 around 1400 articles were published.
42,43
 It is unclear at this stage 
whether patient experience measures will eventually attract similar interest among researchers 
and healthcare services alike, to further develop, validate and implement patient experience 
measures. 
 
Limitations of the Review 
The central limitation of this review of cancer patient experience measures is the potential non-
inclusion of relevant articles and unpublished material. Our search strategy relied on key words 
assigned by authors and may have missed studies that are relevant to the review but were not 
identified. Another limitation is the assessment of psychometric properties which was based on 
individual study acknowledgement of testing, hence the quality of psychometric properties of 
instruments was not identified which may mean an overestimation of the psychometric 
performance of instruments or items therein. Finally, any cancer patient experience measures or 
items within existing quality of life instruments were not included in this review leading to a 
potential underestimation of available cancer patient experience measures. 
 
Conclusion 
Cancer patient experience measures are used, normally alongside other cancer patient reported 
measures, as indicators of quality cancer care. The currently available studies that inform the 
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precision across various psychometric properties of survey instruments, and have been tested for 
various purposes on different cohorts, in different settings and countries. While measures of 
cancer patient experience are not routinely collected in a systematic and consistent way, there are 
results from a number of research studies that include at least some validated or partially 
validated indicators of cancer patient experience that could be used to inform and drive further 
cancer patient experience indicator development. 
Conflict 
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2009 
+ + 0           ?                 ? ? ? ? 
Wright 2005 + + +           +                + ? ? ? 


































Main Author, Year, Aim 







score     Arora et al. (2011)  
Aim: Develop and test a 
comprehensive survey  
to assess cancer survivors‟ perceptions 
of the quality of their follow-up care; 
identify the sociodemographic, clinical, 
and follow-up care related factors 
associated with survivors‟ quality-of-
care assessments; and evaluate the 
association between survivors‟ 
assessments of the quality of individual 
aspects of care with their overall 




 Cancer registry recruitment of leukaemia, 
bladder, and colorectal cancer survivors aged 
20+ diagnosed 2 to 5 years previously.  
 All survey items underwent cognitive testing 
with 9 cancer survivors (with diversity in age, 
race, sex, and cancer type) to ensure items 
were understandable  





Assessment of Patient Perspectives on Cancer  
Care (APECC) survey includes 33 items taken 
largely from existing instruments. 11 new 
items added by investigators. Three key 
domains (Access-related items; Physician-











 Bo ij e  al. (2013) 
Aim: Develop a quality cancer care 
questionnaire for the European 
Organisation for Research and 
Treatment of Cancer (EORTC) to 
measure cancer patients‟ 















 Recruitment via national insurance company. 
 Expert group (healthcare professionals, patient 
organisations, health insurers and researchers) 
established and consulted for decisions on the 
creation and adaptation of the questionnaire. 
 Three focus group discussions held with 24 
cancer patients to analyse the importance of 
questions. 
 Respondents over 18; had any type of cancer; 
last treatment <2 years prior to focus 









Instrument (12 domains, 99 items) derived 
from focus group findings and additional 
items from EORTC-IN-PATSAT32 
questionnaire to assess cancer inpatient 
satisfaction; the CQI breast care to assess 
patients‟ experiences with breast care; the 
CQI hospital care to measure the hospital 
care quality and other items from the 
Netherlands patient consumer federation. 
Twelve domains: personal attention during 
aftercare; cooperation and communication 
between healthcare professionals; freedom 
of choice; skills and cooperation of 
healthcare professionals; psychosocial 
guidance; other investigations and 
treatments; information during treatment; 
continuity of care by healthcare 
professionals/side effects and complaints; 
patient-centred approach by doctors; 
patient-centred approach by nurses; 
information at completion of treatment; 














Boyes A. et al (2009)  
Aim: Develop and validate a short 
version of the Supportive Care Needs 
Survey (SCNS-LF59) to reduce 
respondent burden without 
compromising the psychometric 
properties of the original instrument  
 
Secondary analyses of the data from two studies.  
The Supportive Care Review was conducted in 
1995 and assessed the supportive care needs of 888 
adult cancer patients using the SCNS-LF59. 
Unpublished baseline data collected from the first 
250 participants in the Cancer Survival Study was 
used to test the convergent validity of the short-




New instrument (SCNS-SF34) has 34 items 
within five domains: (psychological, health 
system and information, physical and daily 
living, patient care and support, and sexuality 
needs). New instrument maintained the 
psychometric properties of the original 
instrument (content validity, construct validity 
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Brédart et al. (2005)  
Aim: Study objective was to assess the 
psychometric properties of the European 
Organisation for Research and 
Treatment of Cancer (EORTC) IN-
PATSAT32 when used in a large, 
international, cross-cultural context (The 
EORTC QLQ-SAT32 is designed to 
evaluate the cancer inpatient‟s 
perception of the quality of medical and 
nursing care, and the organisation of 
care and services received during 
admission to an oncology unit).  
 
 Patients diagnosed with cancer, aged 18+, 
hospitalised for at least three days, and be 
mentally fit to complete a questionnaire.  
 Patients N=647 from collaborating hospitals in 
nine countries completed the EORTC IN-
PATSAT32  
 Self-administered tool given to patients while in 
hospital to complete at home and post back 
within 6 weeks of discharge. A reminder letter 
sent if the questionnaire was not returned and, 
where necessary, was followed by a telephone 
reminder. 
 
The EORTC QLQ-SAT32 has 32 items 
divided across three Domains evaluating: (1) 
the medical team; (2) the nursing team; (3) 
organisation of care and services; and 




Brédart et al. (2011)  
Aim: Validate a questionnaire (SAT-
RAR) on patients‟ perception of care 
quality during radiotherapy for breast or 
lung cancer. 
 
 Questionnaire developed in several steps: (a) 
review of the literature (b) selection of items 
according to relevant themes identified in the 
literature and based on a cancer care satisfaction 
previously developed questionnaire (c) pilot 
testing of the preliminary questionnaire on 10 
patients during radiotherapy in order to evaluate 
its relevance, content validity, 
comprehensibility, redundant items.  
 Patients with non-small cell lung cancer or breast 
cancer, from 16 radiotherapy centres, who were 
age > 18 years; curative irradiation and 
satisfactory general status (<3 on the WHO 
performance scale) (n=297, response rate 56%) 
 
Psychometric analyses indicate scales validly 
and consistently measuring patient‟s perception 
of: form and timing of the information received; 
perception of the radiotherapist/radiotherapy 
technicians; emotional and physical experience 
of treatment; and global satisfaction with care 
(23 items). Scales able to differentiate patients‟ 
responses according to radiotherapy modalities.  
 
7/10 
    Damman et al. (2009)  
Aim: Develop an instrument - CQ-
index Breast Care (CQI-BC) 
instrument to measure the care 
experience from the breast cancer 
patient perspective 
 
 Three focus group discussions to determine items 
for inclusion in pilot questionnaire, 27 patients (n 
= 11, n = 9 and n = 7).  
 Pilot oral questionnaire completed by 731 
women (response 63%) filled in the experience 
survey. Selected from claims data of four health 
insurance companies. 
 Participants had various stages of diagnosis and 
disease progression; must have had breast care 
within previous 24 months 
 
The final instrument has 152 items, of which 
118 items regarded patients‟ experiences. 12 
domains: Conduct of professionals during 
breast examination; Conduct of general 
practitioner Integrated & coordinated care; 
Conduct of nurses; Conduct of surgeon; 
Autonomy regarding treatment; Autonomy 
regarding follow-up treatment; Conduct of 
professionals during radiotherapy; Information 
on radiotherapy; Conduct of professionals 
during chemotherapy; Information on 
chemotherapy; Cooperation; Accessibility of 
care; Continuity psychosocial care; Continuity 




de Kok et al. (2007)  
Aim: Develop an instrument to assess 
quality of care in breast cancer patients.  
 
 Cancer patients‟ participants across a range of 
treatment modalities recruited from five 
hospitals.  
 Focus groups followed by concept mapping to 
determine relevant items for inclusion. 72 
participants across eight focus groups. 67 
participants across the six concept map meetings. 
Focus group participants had curative surgery in 
the previous 15 months; concept mapping 
participants had surgery in the previous 12 
months.  
 Software programme based on multidimensional 
scaling and hierarchical cluster analysis used for 
analysis of the concept map data. This resulted in 
visual displays („concept maps‟) depicting 
relationships in clusters between the aspects that 
had been grouped by the participants. 
 
6 key domains (55 items): time schedule; 
education; focus on the patient; continuity of 
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    de Kok et al. (2010)  
Aim: Test a pilot instrument of 
assessment of professionals‟ 
performance and patients‟ needs in the 
care process from the perspective of 
breast cancer patients  
 
 A pilot questionnaire was developed and sent by 
post to all breast cancer patients 17+ and mental 
competence as judged by the breast nurse and 
operated on in the previous 3 to 15 months in five 
participating hospitals (n=276 and response rate 
43%).  
 Recruitment from 5 hospitals in the Netherlands.  
 
Five key domains (33 items):  patient 
education regarding aspects related to 
postoperative treatment, services by the 
breast nurse, services by the surgeon, patient 
education regarding activities at home and 
patient education regarding aspects related 
to preoperative treatment 
 
8/10 
   Defossez et al. (2007)  
Aim: Adapt existing Consumer 
Satisfaction Survey (validated in French) 
 Literature review and two focus groups with 30 
breast cancer patients used to generate items and 
identify domains.  
 Test questionnaire trialled with breast cancer 
patients to assess understanding and 
comprehensiveness of items.  
 Postal survey of 850 (87% response) patients 
from two regions to validate new 
questionnaire. Sent one month after end of 
initial treatment. Recruitment via public and 
private cancer centres in two regions, France. 




Dev loped additional items based on pati nt 
f cus groups and xperts‟ input to measure 
breast cancer patients‟ satisfaction of care. Sixty 
items, 13 domains: Access to primary care; 
Access to secondary care; Competence and 
communication skills of primary care doctors; 
Competence of secondary care doctors; 
Communication skills of secondary care 
doctors; Choice among different doctors; 
Human qualities of doctors; Global 
satisfaction; Cover for medical expenses; 
Listening abilities and information provided by 
doctors; Organisation and follow-up of medical 





    Fitch, M. and McAndrew, A. (2011)  
Aim: Develop a measure to gather 
patient feedback regarding information 
given to them in healthcare visits.  
 
 The issues cancer patients previously reported of 
importance to them selected as domains for the 
n w instrument 
 Tested for clarity in 10 patients attending an 
outpatient appointment. 
 Convenience sample of 540 cancer patients with 
a large range of cancers and in various stages of 
diagnosis/treatment approached in the waiting 
area of one ambulatory clinic.  
 Self-administered questionnaire on-site 
(outpatient setting) 
 
Two key domains (24 items): Information 
importance; Information satisfaction 
 
7/10 
  Harley et al. (2009)  
Aim: Adapt the Components of Primary 
Care Index (CPCI) to be applicable to 
oncology outpatients and assess the 
reliability and validity of the adapted 
instrument (renamed the Medical Care 
Questionnaire [MCQ]). 
 Instrument development in phases (1) reviewed 
th  literature and examined existing measures (2) 
ected strument (CPCI) reviewed by an 
expert pa el us  a stepwise consensus 
procedure (3) Adapted 21-item MCQ 
administered to 200 outpatients attending 
oncology appointments - instrument refined (4) 
21-item MCQ completed by 477 oncology 
outpatients (in hospital and by post) who could 
read and understand English and were not 
exhibiting overt cognitive dysfunction or signs of 
distress.  
 Recruitment from a regional hospital, England 
 
Three domains (15 items) continuity of care: 
“Communication” with doctors; 
“Coordination” of medical information and 
physicians‟ accumulated knowledge about the 
patient; and “Preferences” to see usual doctor. 
 
7/10 
  Iversen, H. et al (2012)  
Aim: Describe the development and 
psychometric evaluation of the Cancer 
Patient Experiences Questionnaire 
(CPEQ) in Norway. 
 
 Instrument development in phases (1) literature 
review of existing questionnaires (2) patient 
interviews (3) expert-group consultations (4) 
pretesting questionnaire (5) national survey.  
 Questionnaire tested in interview with 12 patients  
 Postal survey of 7,212 cancer patients attending 
54 hospitals in all 4 health regions.  
 Adult cancer patients who attended an outpatient 
clinic or been discharged from an inpatient ward. 
Patients with all types of cancer were included. 
 
The final questionnaire has six domains of 
outpatient experiences (127 items): nurse 
contact; doctor contact; information; 
organisation; patient safety; contact with 
next of kin. Seven scales for inpatient 
experiences: as above plus hospital standard. 
The questionnaire also includes items about 
hospital care not directly related to either 
outpatient or inpatient services, addressing 
the hospitals‟ extra-medical services, 
cooperation with the primary doctor and 
other community services, and information 
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   Jean-Pierre et al. (2011)  
Aim of this study was to develop a 
patient satisfaction with cancer care 
measure that is relevant to patients 
receiving diagnostic/therapeutic cancer-
related care.  
 
 Instrument development in phases (1) conceptual 
framework (2) operational definition of patient 
satisfaction with cancer care (3) an item pool 
based on literature review, expert feedback, 
group discussion, and consensus (4) 35-item 
Patient Satisfaction with Cancer Care measure 
administered to 891 participants from the 
multisite NCI-sponsored Patient Navigation 
Research Program.  
 Surveys read aloud to 891 participants (within 
nine largely racial/ethnic minority and low 
income communities) during a visit to hospital 
or clinic. 
 
One domain (18 items) – satisfaction with 
cancer care. Example items: I felt that my 
health concerns were understood; I felt that I 
was treated with courtesy and respect; I felt 
included in decisions about my health; I was 
told how to take care of myself; I felt 
encouraged to talk about my personal health 
concerns; I felt I had enough time with my 





  Kleeberg et al. (2005)  
Aim: Multicentre study to Assess quality 
of life and patient satisfaction using the 
Patient Satisfaction and Quality in 
Oncological Care (PASQOC) survey as a 
basis for a redesigned instrument.  
 
 Focus group discussions with 29 patients in four 
centr s using inq iry charts nd metaplan 
techniqu  for each subject area. 
 PASQOC tool plus the SF-36 were distributed 
(postal return) to a random sample of 3384 
cancer patients (age ≥18 years, the presence of 
any cancer disease suitable for outpatient 
treatment, able to communicate in German, who 
presented at 24 investigators‟ offices 
nationwide). 
 A total of 2659 questionnaires evaluated (78.6% 
response rate)  
 
Final version the PASQOC questionnaire 
comprised 120 items in 15 domains including: 
contact with the care team, care by the 
physician in attendance, general set-up of the 
treatment, waiting period.  
 
6/10 
   Kritsotakis G, et al (2009)  
Aim: Translate and psychometrically 
validate the „Comprehensive Assessment 
of Satisfaction with Care‟ (CASC) in a 
Greek population (CASC-G). 
 All cancer patients admitted consecutively in the 
department of Medical Oncology in a central 
hospital of Athens for a period of 10 weeks 
invited to participate in the study during their first 
hospitalisation (18–79 years, communicative and 
mentally healthy, able to understand and speak 
Greek and stayed at least two nights in the 
hospital. 
 Postal pilot study in 10 patients prior to 
interview-based assessment of CASC with 





 day of hospitalisation.  
CASC comprises 61 items that form domains 
to evaluate different aspects of both inpatient 
and outpatient dimensions of cancer care, i.e. 
medical, nursing and administrative.  
 
7/10 
  Llewellyn et al. (2006)  
Aim: Develop and examine the 
psychometric properties of the 
Satisfaction with Cancer Information 
Profile (SCIP) a new measure designed 
to assess the extent to which patients 
with head and neck cancer are satisfied 
with information received about their 
treatment.  
 
 SCIP developed from basis of an existing tool 
(SIMS), additional items devised after interviews 
with patients. 
 Recruitment: 82 newly diagnosed patients from 
four hospitals, England. Survey completed before 
and one month after treatment. 
 
 
Two domains (21 items): Satisfaction with the 
amount and content of information; 




Lo C, et l (2009)  
 
Aim: Exploratory psychometric analysis 
of the Family Care scale adapted for 
patient use - FAMCARE-Patient 
(FAMCARE-P), to assess satisfaction 
with outpatient care in advanced cancer 
patients.  
 
 N=145 outpatients (71% response) (with 
advanced cancer, at least 18 years old, fluent in 
English) who were participating in a phase II trial 
of an outpatient palliative care intervention.  
 Patients completed the modified FAMCARE 
measure and the Edmonton Symptom Assessment 
Scale, a measure of symptom burden at baseline 
and 1 week and 1 month after their Oncology 
Palliative Care Clinic consultation. 
The FAMCARE scale is a 20-item self-report 
measure Items include questions such as 
„„availability of doctors to answer your 
questions,‟‟ „„availability of nurses to answer 
your questions,‟‟ and „„availability of the 
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     Malin et al. (2006)  
Aim: Assess newly diagnosed lung and 
colorectal cancer patients on their 
personal characteristics, decision 
making, experience of care, and 
outcomes using the baseline CanCORS 
patient survey. 
 
 Survey developed from expert opinion and 
adaptation of previously validated tools. 
Questions about patients‟ experiences of their 
care were adapted from several existing surveys, 
including Consumer Assessment of Health Plans 
Study (CAHPS) adult core survey, a survey of 
cancer patients developed by the Picker Institute, 
the Northern California Colorectal Cancer Study 
Patient Survey, and the NCI‟s Assessment of 
Patients‟ Experience of Cancer Care (APECC) 
 Survey was designed to capture information 
about the initial treatment decision-making 
process - administered approximately 4 months 
post-diagnosis. 
 Initial pilot study used to evaluate the feasibility 
of a lengthy and clinically detailed interview with 
ill patients undergoing treatment for lung or 
colorectal cancer in a convenience sample of 
recently diagnosed patients. Administered within 
8 months of diagnosis (lung, colon or rectal 
cancer) in 71 patients from six sites in person (18 







Twelve (12) Domains. Examples of patient 
experience items: reports of specific aspects of 
care: coordination of care, information 






   Ouwens et al. (2007)  
Aim: Development of measures to assess 
the process of care for patients with head 
and neck cancer  
 Development of measures based on integrated 
care literature, national evidence-based guidelines 
for patients with head and neck cancer, and the 
opinions of professionals and patients 
 15 professionals and 30 patients individually 
interviewed. 
 Indicators tested via postal survey on a 
population of 189 newly referred patients (newly 
diagnosed between May to December 2003 with 
head and neck cancer). 
 Recruitment via clinic lists from a university 
hospital in the Netherlands.  
The set of 23 experience indicators broadly 
divided into 3 domains of quality of care: 
patient-oriented quality of care, 
organizational quality of care, and 





  Ouwens et al. (2010)  
Aim - Develop indicators of patient-
centred cancer care and tested on a 
population of patients with Non-Small 
Cell Lung Cancer (NSCLC).  
 
 Recommendations for patient-centred care 
extracted from clinical guidelines, and patients 
and consumers interviewed (n=30 head and neck 
cancer and n=7 patient representatives). 
Recommendations translated into measures and 
developed into a questionnaire.  
 Patients newly diagnosed non-small cell lung 
cancer treated in six hospitals in the Netherlands. 
All patients received the questionnaire (postal 
survey) 2 to 6 months after their first visit to the 
pulmonologist (n=100 67% response rate).  
 
56 items across 8 domains (Access, Follow-
Up, Communication and Respect, Patient and 
Family Involvement, Information, 
Coordination, Physical Support, Emotional 
and psychological support). 
9/10 
   Tarrant et al. (2009)  
Aim: Formally evaluate the Prostate 
Care Questionnaire (PCP-Q)  reliability, 
validity and acceptability to patients and 
service providers (The PCP-Q is a 
measure developed from research 
designed to determine the issues most 
important to prostate cancer patients, 
including a literature review of the 
experiences of patients of prostate 
cancer care, and interviews with 
patients and service providers) 
 
 Each of 5 hospitals drew a consecutive sample of 
all patients diagnosed with, or treated for, 
prostate cancer within the past two years & at 
different stages of care. Postal questionnaires 
were returned by 865 patients (69.2%); 355 
completed Sections A, B, C and F (response rate: 
61%), and 510 completed Sections D, E and F 
(response rate: 77.7%).  
 To assess criterion validity, 935 patients were 
also sent sections of the National Centre for 
Social Research Shortened Questionnaire; to 
assess test-retest reliability, 296 patients who 
responded to the questionnaire were resent it a 
second time three weeks later. A subsample of 20 
prostate cancer patients from one hospital took 
part in qualitative interviews to assess validity 
and acceptability of the PCP-Q.  
 
PCP-Q questionnaire is divided into five 
sections- Section A: GP visits and referral; 
Explanation Experience of referral; Taking 
the problem seriously. Section B: Tests at the 
hospital; Explanation & support; Quality of 
care; Appointment. Section C: Diagnosis and 
treatment decision; Explanation & support; 
Making treatment decision; Getting the 
diagnosis; Length of wait. Section D: 
Treatment and discharge; Preparation for 
discharge; Treatment; Information. Section E: 
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Teno JM, et al. (2009) 
 
Aim: Validation of new measures of 
the quality of care at the time of 
diagnosis and treatment for life-
limiting advanced cancer. 
 
 Measures developed via focus groups, review of 
guidelines, and an expert panel were used to 
construct two surveys of the quality of cancer 
care. 
 First survey administered shortly after diagnosis 
with or progressed to an advanced stage of cancer 
(n=206). Second survey administered 1 to 2 
months later post completion of at least one 
treatment cycle. Of the 206 time 1 respondents, 
162 patients participated in a second interview.  
 Twenty-three respondents volunteered to have the 
survey administered again 48 to 72 hours later to 
enable examination of the short term reliability. 
 
Three domains (45 items): Communication at 
the time of diagnosis; Communication at the 
time of treatment decision making; Cancer 
patient experience of treatments. Example 
items: How often do your cancer care 
providers allow your family/friends to ask as 
many questions as they want about your 
treatment plan? How often would you say 
that your oncologist and cancer care 
providers work together as a team? 
 
9/10 
    Trask et al. (2008)  
  
Aim: Psychometric testing of the Cancer 
Therapy     Satisfaction Questionnaire 
(CTSQ) 
 Cancer Therapy Satisfaction Questionnaire 
(CTSQ) was originally developed after inter iews 
and focus groups with patients 
 A total of 361 participants (18 years or+, English 
literate, available for follow-up evaluation, and 
receiving treatment). Study participants randomly 
assigned to complete either the baseline 
assessment only or both the baseline and follow-
up assessments. A subsample of 88 participants 
completed follow-up questionnaires 1 week after 
their baseline assessment.  
 361 patients recruited for survey and 88 of these 
selected for one week follow-up with a diagnosis 
of breast, colorectal, lung cancer or melanoma; 
recruited from 14 sites in the USA 
 
Final version of the CTSQ has 16 items and 3 
domains: Expectations of Therapy, Feelings 





   van Weert et al. (2009)  
Aim: Develop and assess psychometric 




 (QUOTE - Quality Of care Through the 
patients‟ Eyes) to measure needs and 
experiences with communication 
preceding chemotherapy treatment.  
 
 Items developed via existing measure, literature 
review and five focus group interviews (n = 33) 
as well as one-to-one interviews with cancer 
patients (n = 5). 
 Eligible patients to test the instrument identified 
through the hospital records of 10 hospitals in the 
Netherlands. The QUOTEchemo questionnaire 
was sent to patients of each hospital that had 
started Cancer Therapy (CT). Patients were 
eligible if they were new to CT; aged 18 years or 
+ and able to read Dutch. 345 patients returned 
the questionnaire. 
 
Seven key domains (67 items): Treatment-
related information, Prognosis information, 
Rehabilitation information, Coping 
information, Interpersonal communication, 






  Wright EP. et al (2005)  
Aim: Develop and preliminarily evaluate 
a Social Difficulties Inventory (SDI) for 
use in oncology practice. 
 Items developed via (a) existing measures, (b) 
literature revie , (c) 18 patient focus groups and 
12 patient interviews involving 96 purposively 
selected patients and (d) staff (49 health/social 
welfare oncology professionals - 7 focus groups). 
 Expert review panel to assess content validity. 
 Questions constructed and pre-tested (n = 42)  
 Psychometric evaluation (n = 271) to assess 
frequency of endorsement, factor structure, 
summated scales and construct validity followed 
by randomisation to criterion validity or test-
retest arms. 
Twenty one items with three key domains i.e. 
Physical ability, Providing for the family and 
Contact with others. Examples of questions 
include: Have you had any difficulty 
maintaining your independence? Have you 
had any difficulty in carrying out your 
domestic chores? (e.g. cleaning, gardening, 
cooking, shopping) Have you had any 
difficulty with managing your own personal 
care? (e.g. bathing, dressing, washing) Have 
you had any difficulty with looking after those 
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 Young et al. (2011)  
 
Aim: Develop a questionnaire to 
measure patient experience of cancer 
care coordination 
 
 Questionnaire items developed on the basis of 
literature review, focus groups and interviews 
with cancer patients, carers and clinicians.  
 686 English speaking patients recently treated for 
newly diagnosed cancer, from 28 centres in New 
South Wales completed the self-administered 
questionnaire 
 Sample 1: patients (n= 245) recruited who had 
been treated between three and 12 months 
previously (considered optimal timing as patients 
assumed to have experienced full range of care 
coordination)  
 Sample 2: patients (n=441) newly diagnosed, 
recruited at initial surgical treatment; asked to 
complete questionnaires at baseline, one, three 




Final instrument has 2 key domains 
„Communication‟ and „Navigation‟. Twenty 
items including: organisation of patient care, 
access to and navigation through the 
healthcare system, the allocation of a “key 
contact” person, recognition and 
understanding of medical team roles, 
effective communication and cooperation 
amongst the multidisciplinary team and other 
health service providers, delivery of services 
in a complementary and timely manner, 
needs assessment and sufficient and timely 



















































Excluded on the basis 
of abstract
 n = 280
Excluded on the basis 
of title
 n = 296
Additional papers found through:
    - Hand searching
    - Contact with experts
                   n = 3
Full copies of papers retrieved
 n = 54
Relevant papers
 n = 26
 
 
Fig. 1 Flow chart summarising number of studies identified and ultimately included 
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